skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Morning,

CXR having a bit of an off day today. I wonder if you think the recent strength has been based on business fundamentals or speculation of a deal?

Assuming that there is no deal to be found, I think you might still find it a worthy hold as it was recently a 5i top pick on BNN. Is that still the case? What would be the argument in favour of buying more?

If a deal were to occur, within what time frame might it be reasonable to expect?
Read Answer Asked by Tim on May 31, 2016
Q: If you could please comment on this U.S. company IMS Healthcare. I would greatly appreciate it. Can you classify it as tech or healthcare and how it compares to its historical data PE/PCF/PB and any other fundamental that is important to you. Would you still prefer GUD over this stock? My worry with GUD is that they do not use their cash and investors become irritated and fickle. I can benefit from IMS as it diversifies my portfolio a little more to the US.I am thinking of a 1 to 3 year hold minimum. Thank You
Read Answer Asked by Jeremy on May 30, 2016
Q: Hi Peter and Ryan,

I'm interested in getting exposure to the health care sector by using an available ETF. I ran across this one (IHI) through my research and would appreciate your analysis of the ETF. I think this one focusses on medical devices. Please let me know what you think the future holds for the ETF. If you think there are other investments that would be preferable I would appreciate your suggestions.
Read Answer Asked by Les on May 30, 2016
Q: How do you feel about the current valuation of Biosyent? They announced yesterday that they have signed a new agreement for distribution of a cardiovascular drug that they expect will add $20M to annual revenue over time (2015 FY rev was $15.39M). Assuming they can do what they say (which they have done well at in the past) do you think the share price is reasonable? This company seems to operate with great margins and is growing with free cash flow. They have $0 in debt
Read Answer Asked by Michael on May 27, 2016
Q: On Ron's question about short interest on CXRX, it is important to note the settlement date on the website is May 13. This is the same day Concordia released first quarter earnings and then the stock price has increased significantly. I suspect there was some short covering and the next update to the website for short interest will be key.
Read Answer Asked by James on May 25, 2016
Q: i own anip a pharma in the usa i am ahead on this stock should i sall or do you see a future thanks bill
Read Answer Asked by William on May 24, 2016
Q: I was just looking at the fundamentals provided by my on-line service CIBC Investors Edge for this company: when I look at EPS last 4 Qt it shows just over $5.00; yet, on a TTM EPS basis it shows -300%+ growth, debt to equity over 3X and negative ROE. How can you make $5.00 per share and have negative ROE: especially, when they have been making money and on a cash basis generating a ton of cash? What am I missing and is this a good stock to hold for a recovery??
Read Answer Asked by James on May 24, 2016
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!